Member access

4-Traders Homepage  >  Shares  >  Euronext Bruxelles  >  UCB    UCB   BE0003739530

UCB (UCB)

282
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
09/08/2014 09/09/2014 09/10/2014 09/11/2014 09/12/2014 Date
71.04(c) 70.31(c) 70.08(c) 69.98(c) 69.72(c) Last
340 202 255 337 309 207 241 986 216 747 Volume
-0.08% -1.03% -0.33% -0.14% -0.37% Change
More quotes
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders. The company focuses on the development of innovative medicines. It sells bio-pharmaceutical products for... 
Sector
Pharmaceuticals
Calendar
10/23Earnings Release
Surperformance© rating of UCB
Trading Rating : Investor Rating :
More about the company
Chart UCB
Duration : Period :
UCB Technical Analysis Chart | UCB | BE0003739530 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 3 525 M
EBIT 2014 510 M
Net income 2014 260 M
Debt 2014 1 512 M
Yield 2014 1,51%
Sales 2015 3 775 M
EBIT 2015 647 M
Net income 2015 380 M
Debt 2015 1 366 M
Yield 2015 1,74%
PER 2014 50,19
PER 2015 34,01
EV / Sales 2014 4,28x
EV / Sales 2015 3,95x
Capitalization 13 561 M
More Financials
Latest news on UCB
4d ago Eastman Chemical to buy Taminco for $1.8 bln
5d ago UCB : Patent Application Titled "Pharmaceutical Composition Comprising Rotigotin..
08/05 EXCLUSIVE : Belgium's UCB explores sale of generics unit Kremers Urban - sources
08/01 UCB : Expands Access to Clinical Study Data (Transparency and Sharing)
07/28 Pfizer's need for deal looms larger with earnings report
07/04 UCB : Acquisition of own shares
06/25 UCB : Patent Issued for Pharmaceutical Composition Comprising Rotigotine Salts (..
06/25 UCB : Acquisition of own shares
06/11 UCB : Patent Issued for Chiral Intermediate, Process for Producing the Same and ..
05/06 UCB : Acquisition of own shares
05/05 UCB : Kremers Urban Pharmaceuticals Assigned Patent
04/29 UCB : ex-dividend day for annual dividend
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
UCB : Income Statement Evolution
More Financials
EPS Revisions
UCB : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF